image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Plus500

January 2017

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • PLUS
  • Price:
  • 375p
The shares fell sharply after the UK’s Financial Conduct Authority announced tougher rules for firms selling contracts for difference (CFDs) to retail customers. The proposals seek to better illustrate the risks associated with these products and limit leverage to 25:1 (i.e. £4 client money and £96 borrowing for a £100 bet) for inexperienced clients and cap total leverage for everyone to 50:1 for retail clients compared with current allowable leverage of 200:1. It’s also proposing to prevent account opening bonuses and forcing disclosure of customers’ loss ratios in their portfolios.For Plus 500, whose only product is CFD trading, it’s obviously a blow but as only 18% of revenues come from ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X